Larimar Therapeutics Newsroom

JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21

Futu News02:41

Baird Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $13

Futu NewsDec 18 00:31

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Futu NewsDec 17 21:31

A Quick Look at Today's Ratings for Larimar Therapeutics(LRMR.US), With a Forecast Between $14 to $36

Futu NewsDec 17 21:00

Analysts Offer Insights on Healthcare Companies: Larimar Therapeutics (LRMR) and Ascendis Pharma (ASND)

TipRanksDec 17 02:28

Larimar Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow JonesDec 17 01:12

Promising Developments and Strategic Regulatory Support Justify Buy Rating for Larimar Therapeutics

TipRanksDec 17 01:08

Larimar Therapeutics Analyst Ratings

BenzingaDec 17 01:02

LifeSci Capital Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $36

Futu NewsDec 7 00:31

Positive Outlook on Larimar Therapeutics' Nomlabofusp for Friedreich's Ataxia: Analyst Recommends Buy Rating

TipRanksDec 6 23:47

JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $21

Futu NewsDec 6 01:35

Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), Larimar Therapeutics (LRMR) and Merus (MRUS)

TipRanksDec 6 01:28

H.C. Wainwright Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 19 16:42

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Futu NewsNov 1 20:31

Larimar Therapeutics Analyst Ratings

BenzingaOct 31 17:42

Citi Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $14

Futu NewsOct 31 10:33

LifeSci Capital Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $36

Futu NewsOct 31 00:31

H.C. Wainwright Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $15

Futu NewsOct 31 00:31

Leerink Partners Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $25

Futu NewsOct 28 20:36

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Futu NewsOct 16 20:34